192 related articles for article (PubMed ID: 24218041)
1. Increased intravitreal angiopoietin-2 levels associated with rhegmatogenous retinal detachment.
Loukovaara S; Lehti K; Robciuc A; Pessi T; Holopainen JM; Koli K; Immonen I; Keski-Oja J
Graefes Arch Clin Exp Ophthalmol; 2014 Jun; 252(6):881-8. PubMed ID: 24218041
[TBL] [Abstract][Full Text] [Related]
2. Ang-2 upregulation correlates with increased levels of MMP-9, VEGF, EPO and TGFβ1 in diabetic eyes undergoing vitrectomy.
Loukovaara S; Robciuc A; Holopainen JM; Lehti K; Pessi T; Liinamaa J; Kukkonen KT; Jauhiainen M; Koli K; Keski-Oja J; Immonen I
Acta Ophthalmol; 2013 Sep; 91(6):531-9. PubMed ID: 23106921
[TBL] [Abstract][Full Text] [Related]
3. Statins in rhegmatogenous retinal detachment are associated with low intravitreal angiopoietin-2, VEGF and MMP-2 levels, and improved visual acuity gain in vitrectomized patients.
Tuuminen R; Haukka J; Loukovaara S
Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1685-93. PubMed ID: 25432094
[TBL] [Abstract][Full Text] [Related]
4. Elevated erythropoietin in vitreous of patients with rhegmatogenous retinal detachment and proliferative vitreoretinopathy.
Wang ZY; Shen LJ; Zhao KK; Song ZM; Qu J
Ophthalmic Res; 2009; 42(3):138-40. PubMed ID: 19602911
[TBL] [Abstract][Full Text] [Related]
5. Low intravitreal angiopoietin-2 and VEGF levels in vitrectomized diabetic patients with simvastatin treatment.
Tuuminen R; Sahanne S; Loukovaara S
Acta Ophthalmol; 2014 Nov; 92(7):675-81. PubMed ID: 24506800
[TBL] [Abstract][Full Text] [Related]
6. Comparison of interleukin-6 and matrix metalloproteinase expression in the subretinal fluid and the vitreous during proliferative vitreoretinopathy: correlations with extent, duration of RRD and PVR grade.
Symeonidis C; Papakonstantinou E; Androudi S; Georgalas I; Rotsos T; Karakiulakis G; Diza E; Dimitrakos SA
Cytokine; 2014 Jun; 67(2):71-6. PubMed ID: 24725542
[TBL] [Abstract][Full Text] [Related]
7. Balance of vascular endothelial growth factor and pigment epithelial growth factor prior to development of proliferative vitreoretinopathy.
Dieudonné SC; La Heij EC; Diederen RM; Kessels AG; Liem AT; Kijlstra A; Hendrikse F
Ophthalmic Res; 2007; 39(3):148-54. PubMed ID: 17534114
[TBL] [Abstract][Full Text] [Related]
8. Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study.
Begum G; O'Neill J; Chaudhary R; Blachford K; Snead DRJ; Berry M; Scott RAH; Logan A; Blanch RJ
Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4929-4936. PubMed ID: 30347087
[TBL] [Abstract][Full Text] [Related]
9. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy.
Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001
[TBL] [Abstract][Full Text] [Related]
10. High intravitreal TGF-β1 and MMP-9 levels in eyes with retinal vein occlusion.
Tuuminen R; Loukovaara S
Eye (Lond); 2014 Sep; 28(9):1095-9. PubMed ID: 24946846
[TBL] [Abstract][Full Text] [Related]
11. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
12. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
13. Vitreous levels of apolipoprotein A1 and retinol binding protein 4 in human rhegmatogenous retinal detachment associated with choroidal detachment.
Ding N; Luo S; Yu J; Zhou Y; Wu Z
Mol Vis; 2018; 24():252-260. PubMed ID: 29618920
[TBL] [Abstract][Full Text] [Related]
14. Vitreous levels of oxidative stress biomarkers and the radical-scavenger α1-microglobulin/A1M in human rhegmatogenous retinal detachment.
Cederlund M; Ghosh F; Arnér K; Andréasson S; Akerström B
Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):725-32. PubMed ID: 22829194
[TBL] [Abstract][Full Text] [Related]
15. Correlation of the extent and duration of rhegmatogenous retinal detachment with the expression of matrix metalloproteinases in the vitreous.
Symeonidis C; Diza E; Papakonstantinou E; Souliou E; Dimitrakos SA; Karakiulakis G
Retina; 2007; 27(9):1279-85. PubMed ID: 18046238
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Chemokine CXCL-1 and Interleukin-6 Concentrations in the Subretinal Fluid and Vitreous in Rhegmatogenous Retinal Detachment.
Symeonidis C; Rotsos T; Matsou A; Dermenoudi M; Georgalas I; Tsinopoulos I; Makri O; Souliou E; Dimitrakos SA
Ocul Immunol Inflamm; 2021 Feb; 29(2):355-361. PubMed ID: 31661651
[No Abstract] [Full Text] [Related]
17. Interleukin-6 and matrix metalloproteinase expression in the subretinal fluid during proliferative vitreoretinopathy: correlation with extent, duration of RRD and PVR grade.
Symeonidis C; Papakonstantinou E; Androudi S; Tsaousis KT; Tsinopoulos I; Brazitikos P; Karakiulakis G; Diza E; Dimitrakos SA
Cytokine; 2012 Jul; 59(1):184-90. PubMed ID: 22579111
[TBL] [Abstract][Full Text] [Related]
18. Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy.
Limb GA; Chignell AH
Br J Ophthalmol; 1999 Aug; 83(8):953-6. PubMed ID: 10413701
[TBL] [Abstract][Full Text] [Related]
19. Tenascin-C levels in the vitreous of patients with proliferative vitreoretinopathy.
Mitamura Y; Takeuchi S; Ohtsuka K; Matsuda A; Yamamoto T; Yamamoto S; Hiraiwa N; Kusakabe M
Ophthalmologica; 2003; 217(6):422-5. PubMed ID: 14573976
[TBL] [Abstract][Full Text] [Related]
20. Levels of Anti-Retinal Antibodies in Retinal Detachment and Proliferative Vitreoretinopathy.
Ichinohasama R; Nishiguchi KM; Fujita K; Aizawa N; Inoue T; Sasaki E; Kunikata H; Nakazawa T
Curr Eye Res; 2018 Jun; 43(6):804-809. PubMed ID: 29547015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
